|
|
Volumn , Issue 59, 2007, Pages 47-63
|
|
Using exposure-response and biomarkers to streamline early drug development.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANILINE DERIVATIVE;
BIOLOGICAL MARKER;
DRUG;
EFAPROXIRAL;
PROPIONIC ACID DERIVATIVE;
RADIOSENSITIZING AGENT;
ANIMAL;
BINDING SITE;
BIOASSAY;
CHEMISTRY;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG DESIGN;
DRUG INDUSTRY;
HUMAN;
METHODOLOGY;
PHARMACEUTICS;
REVIEW;
TIME;
ALLOSTERIC SITE;
ANILINE COMPOUNDS;
ANIMALS;
BIOLOGICAL MARKERS;
CHEMISTRY, PHARMACEUTICAL;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DESIGN;
DRUG INDUSTRY;
ENDPOINT DETERMINATION;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
PROPIONIC ACIDS;
RADIATION-SENSITIZING AGENTS;
TECHNOLOGY, PHARMACEUTICAL;
TIME FACTORS;
MLCS;
MLOWN;
|
|
EID: 39049185309
PISSN: 09476075
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-540-49529-1_4 Document Type: Review |
|
Times cited : (8)
|
|
References (15)
|
